Initiated enrollment of Phase 1 Study of PRT12396, mutant-selective JAK2V617F inhibitor in patients with polycythemia vera ...
It’s not unusual for a Marvel movie to pull from the comics, or vice versa. Several characters, like the Guardians of the ...
Unexpected genetic benefit: A PTPN22 mutation tied to autoimmune diseases helped mice survive otherwise lethal coronavirus infection by enhancing natural killer cell function. Therapeutic potential: ...
New research from the University of Kansas shows a "risk gene" linked to higher odds of developing autoimmune diseases such ...
A 62-year-old man is poised to become the first person in Canada to be cured of HIV. Ten patients worldwide are considered ...
Her symptoms included feeling emotionless after having a baby and experiencing migraines for the first time in her life.
The hantavirus from the MV Hondius outbreak has been sequenced from samples taken from one of the infected individuals. The ...
A nanobody that stabilizes mutant CFTR from inside the cell, especially when combined with existing drugs, restores ...
Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication of preliminary clinical results from its Phase 1a study of RNK08954 in the ...
ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a clinical-stage company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology ...
Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...
A new study investigates the genetic machinery behind these adaptations and finds that evolution has stuck to a similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results